KENS 5: With coronavirus delta variant spreading, will facemask recommendations return to San Antonio?
July 5, 2021
Dr. Robert Leverence, chief medical officer for UT Health Physicians, is quoted in this story. Watch story
July 5, 2021
Dr. Robert Leverence, chief medical officer for UT Health Physicians, is quoted in this story. Watch story
July 5, 2021
Dimpy P. Shah, MD, PhD, of the Mays Cancer Center, was quoted in a story about a study that shows nearly all patients with cancer developed good immune response to the COVID-19 mRNA vaccines three to four weeks after receiving their second dose. Read more
July 5, 2021
Dr. Ruben Mesa, executive director of the Mays Cancer Center, is quoted in this story about a clinical trial. Read more
July 5, 2021
Dimpy P. Shah, MD, PhD, of the Mays Cancer Center, was quoted in this story published in the Kansas City Star. Read more
July 5, 2021
Dr. Dimpy Shah, Mays Cancer Center and Department of Population Health Sciences, is quoted in this story. Read more
July 5, 2021
Dimpy P. Shah, MD, PhD, and Ruben Mesa, MD, of the Mays Cancer Center, were quoted in a story about a study that shows more than five percent of cancer patients exhibit no immune response to the two-shot COVID-19 vaccine. Read more